A unilateral 6-hydroxydopamine lesion decreases the expression of metabotropic glutamate receptors in rat substantia nigra

Neuroscience Letters

Volumn 351, Issue 3, 2003, Pages 186-190

  Gu, Bing ^a   Zhang, Ying Dong ^a   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

6 Hydroxydopamine; Immunocytochemistry; Metabotropic glutamate receptors; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; BENSERAZIDE; LEVODOPA; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NEUROPROTECTIVE AGENT; OXIDOPAMINE; SANDARACOPIMARIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; EXTRAPYRAMIDAL SYNDROME; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0242499501     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.07.013     Document Type: Article

References (16)

1. Aguirre J.A., Andbjer B., Gonzalez-Baron S., Hansson A., Stromberg I., Agnati L.F., Fuxe K. Group I mGluR antagonist AIDA protects nigra DA cells from MPTP-induced injury. NeuroReport. 12:2001;2615-2617.
2. Betarbet R., Sherer T.B., Greenamyre J.T. Animal models of Parkinson's disease. Bioessays. 24:2002;308-318.
3. Blandini F., Nappi G., Tassorelli C., Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 62:2000;63-88.
4. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
5. Dawson L., Chadha A., Megalou M., Duty S. The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigra or intraventricular administration in the reserpine-treated rat. Br. J. Pharmacol. 129:2000;541-546.
6. Freyaldenhoven T.E., Ali S.F., Schmued L.C. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res. 759:1997;9-17.
7. Kosinski C.M., Standaert D.G., Testa C.M., Penney J.B., Young A.B. Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. Neuroscience. 86:1998;783-798.
8. Marino M.J., Awad H., Poisik O., Wittmann M., Conn P.J. Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia. Amino Acids. 23:2002;185-191.
9. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J. Neurosci. 21:2001;7001-7012.
10. Miranda A.F., Sutton M.A., Beninger R.J., Jhamandas K., Boegman R.J. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behavior and protection by elevation of endogenous kynurenic acid in rattus norvegicus. Neurosci. Lett. 262:1999;81-84.
11. Murray T.K., Messenger M.J., Ward M.A., Woodhouse S., Osborne D.J., Duty S., O'Neill M.J. Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease. Pharmacol. Biochem. Behav. 73:2002;455-466.
12. Rouse S.T., Marino M.J., Bradley S.R., Awad H., Wittmann M., Conn P.J. Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders. Pharmacol. Ther. 88:2000;427-435.
13. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874:2000;123-130.
14. Shimazoe T., Doi Y., Aria I., Yoshimatsu A., Fukumono T., Watanabe S. Both metabotropic glutamate I and II receptors mediated augmentation of dopamine release from the striatum in methamphetamine-sensitized rats. Jpn. J. Pharmacol. 89:2002;85-88.
15. Tolwani R.J., Jakowec M.W., Petzinger G.M., Green S., Waggie K. Experimental models of Parkinson's disease: insights from many models. Lab. Anim. Sci. 49:1999;363-371.
16. Wittmann M., Marino M.J., Conn P.J. Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J. Pharmacol. Exp. Ther. 302:2002;433-441.